Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy

BACKGROUND/AIMS: Cytomegalovirus (CMV) surveillance and preemptive therapy is a widely-used strategy for preventing CMV disease in transplant recipients. However, there are limited data on the incidence and patterns of CMV disease during the preemptive period. Thus, we investigated the incidence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tark, Lee, Yu-Mi, Lee, Sang-Oh, Choi, Sang-Ho, Kim, Yang Soo, Woo, Jun Hee, Sung, Heungsup, Jung, Joo Hee, Shin, Sung, Kim, Young Hoon, Kang, Young-Ah, Lee, Young-Shin, Lee, Jung-Hee, Lee, Je-Hwan, Lee, Kyoo-Hyung, Park, Su-Kil, Han, Duck Jong, Kim, Sung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016278/
https://www.ncbi.nlm.nih.gov/pubmed/27055664
http://dx.doi.org/10.3904/kjim.2015.079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016278/
https://www.ncbi.nlm.nih.gov/pubmed/27055664
http://dx.doi.org/10.3904/kjim.2015.079

Ejemplares similares